| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/21/1996 | CA2154025A1 6-membered nitrogen-containing heteroaryl-oxazolidinones |
| 01/21/1996 | CA2154024A1 Benzofuranyl- and benzothienyloxazolidinones |
| 01/20/1996 | CA2154227A1 Cephalosporins with a substituted benzyloxyimino radical in position 7, process for their preparation and their application as medecines |
| 01/19/1996 | CA2154030A1 Gd-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001273A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | WO1996001272A1 Helicobacter proteins and vaccines |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001261A1 Novel carbapenem derivative |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001116A1 Chicken infectious anemia virus vaccine |
| 01/18/1996 | WO1996001110A2 Anti-hiv triple combination |
| 01/18/1996 | DE4425098A1 7-0-Carbamoyl-Heptose-Derivate, Verfahren zu deren Herstellung und deren Verwendung sowie Screening-Verfahren zu deren Bestimmung 7-0-carbamoyl-heptose derivatives, processes for their preparation and their use, and screening procedures for their determination |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | CA2193489A1 Anti-hiv triple combination |
| 01/17/1996 | EP0692532A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0692028A1 Pharmaceuticals based on papillomaviruses |
| 01/17/1996 | EP0691977A1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
| 01/17/1996 | EP0691853A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION |
| 01/17/1996 | EP0691848A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic |
| 01/17/1996 | EP0674646A4 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use. |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | EP0522128B1 Water-dispersible tablets |
| 01/17/1996 | EP0493480B1 Dehydrodidemnin b |
| 01/17/1996 | EP0314705B1 A novel family of primate hematopoietic growth factors |
| 01/17/1996 | CN1114959A Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and processes for preparing thereof |
| 01/17/1996 | CN1114879A Method of administering azithromycin |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/16/1996 | US5484936 Processes for the preparation of 1,3-bis(1,2,4-triazol-1-yl)-propan-2-ol derivatives |
| 01/16/1996 | US5484926 HIV protease inhibitors |
| 01/16/1996 | US5484921 Condensing an alkylamine with a chlorofluorcarboxyquinoline |
| 01/16/1996 | US5484889 Plant protein useful for treating tumors and HIV infection |
| 01/16/1996 | US5484803 Transcutaneous in vivo activation of photosensitive agents in blood |
| 01/16/1996 | US5484785 Salts of a quinolone-carboxylic acid |
| 01/16/1996 | US5484771 Ribonucleotide reductase inhibitors |
| 01/16/1996 | US5484724 DNA encoding GLSI |
| 01/16/1996 | US5484609 Therapeutic compositions and methods |
| 01/16/1996 | CA1337928C Topically applied gold organic complex |
| 01/15/1996 | CA2153760A1 Marek's disease virus vaccine |
| 01/11/1996 | WO1996000583A1 Polynucleotide vaccine for papillomavirus |
| 01/11/1996 | WO1996000571A1 Antibacterial agent |
| 01/11/1996 | WO1996000570A1 Antibacterial agent |
| 01/11/1996 | WO1996000506A1 Stabilized composition comprising colistin sulfate |
| 01/11/1996 | DE4418690A1 Nucleoside 5'-mono-phosphate ester(s) of glyceryl di:ether derivs. |
| 01/11/1996 | CA2193865A1 Antibacterial agent |
| 01/11/1996 | CA2193104A1 Pharmaceutical compositions containing triclosan or derivatives thereof and edta or egta |
| 01/10/1996 | EP0691403A1 Family of primate IP-3-like hemapoietic growth factors |
| 01/10/1996 | EP0691345A2 HIV protease inhibitor combinations |
| 01/10/1996 | EP0691333A2 Pyrimidine derivatives, process for their preparation and their use as precursors |
| 01/10/1996 | EP0690990A1 Parvovirus receptors and methods of use |
| 01/10/1996 | EP0690924A1 Anti-microbial agents and screening method therefor |
| 01/10/1996 | EP0690917A1 Recombinant epstein-barr virus protein and its use in vaccine |
| 01/10/1996 | EP0690912A1 Recombinant avian adenovirus vector |
| 01/10/1996 | EP0690875A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690865A1 Crystalline benzathine salt of cefonicid and its preparation |
| 01/10/1996 | EP0690864A1 Crystalline ceftiofur free acid |
| 01/10/1996 | EP0690862A1 Novel quinolone derivatives and processes for preparing the same |
| 01/10/1996 | EP0690725A1 Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 01/10/1996 | EP0690724A1 Chlamydia vaccine and process |
| 01/10/1996 | EP0690717A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 01/10/1996 | EP0690716A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH |
| 01/10/1996 | EP0690715A1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 01/10/1996 | EP0563062B1 Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |
| 01/10/1996 | EP0556241B1 Mycobacterium vaccae in the treatment of uveitis |
| 01/10/1996 | EP0487611B1 Herpes simplex virus type 1 mutant |
| 01/10/1996 | EP0482081B1 Antiviral composition |
| 01/10/1996 | CN1114652A 8-amino-pyrido(1,2,3-D,E)(1,3,4) benzoxadiazine derivatives |
| 01/10/1996 | CN1114648A Novel mono- and bicyclic DNA gyrase inhibitors |
| 01/10/1996 | CN1114588A Formulations for orally administered pharmaceutical agents |
| 01/10/1996 | CN1030659C Derivatives of 10, 11, 12, 13-tetrahydrodesmycosin, processes for preparation, and use thereof in pharmaceuticals |
| 01/10/1996 | CN1030657C Method for preparing autibacterial compounds |
| 01/09/1996 | US5482945 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 01/09/1996 | US5482936 Imidazo[4,5-C]quinoline amines |
| 01/09/1996 | US5482928 Biocidal proteins |
| 01/09/1996 | US5482713 Equine herpesvirus recombinant poxvirus vaccine |
| 01/09/1996 | US5482708 Leukemia, proteins are not adjacent in native protein |
| 01/09/1996 | CA2095138C Semduramicin premix |
| 01/09/1996 | CA1337907C Antifungal antibiotic bu-3608 complex |
| 01/06/1996 | CA2153270A1 Hiv protease inhibitor combinations |
| 01/04/1996 | WO1996000232A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF |
| 01/04/1996 | WO1996000229A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/04/1996 | WO1996000082A1 Medical use of bromelain |
| 01/04/1996 | WO1996000068A2 Combination therapy for hiv infection |
| 01/04/1996 | WO1995033467A3 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
| 01/04/1996 | WO1995033464A3 Retroviral protease inhibitor combinations |
| 01/04/1996 | WO1995033049A3 Tbp2 fragments of the transferrine receptor of neisseria meningitidis |
| 01/04/1996 | WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 01/04/1996 | WO1995025806A3 Packaging-deficient lentiviruses |
| 01/04/1996 | CA2193654A1 Medical use of bromelain |
| 01/04/1996 | CA2193373A1 Ribozymes with optimized hybridizing arms, stems, and loops, trna embedded ribozymes and compositions thereof |
| 01/04/1996 | CA2193221A1 Combination therapy for hiv infection |
| 01/03/1996 | EP0690066A1 Phosphinic acid derivatives, their preparation as well as their use |
| 01/03/1996 | EP0689841A1 Powder preparation for healing damaged skin |
| 01/03/1996 | EP0689605A1 Hepatitis b escape mutant specific binding molecules |
| 01/03/1996 | EP0689603A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 01/03/1996 | EP0689602A1 Delivery system controlled through factors associated with hiv and cell |